Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey

Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey

Summary: Background: In January 2018, Ecuador changed its routine immunization schedule by replacing one full dose of inactivated poliovirus vaccine (IPV) administered intramuscularly at 2 months of age with two doses of fractional IPV (1/5th of full dose, fIPV) administered intradermally at 2 and...

Full description

Bibliographic Details
Main Authors: Gabriel Trueba, Vishali Jeyaseelan, Lazaro Lopez, Bernardo A. Mainou, Yiting Zhang, Alvaro Whittembury, Alfredo Jose Olmedo Valarezo, Gonzalo Baquero, Rosa Romero de Aguinaga, Lucia Jeannete Zurita Salinas, Maria Gabriela Santacruz Mancheno, Diana Elizabeth Medina Chacho, Emmanuelle Quentin, Ana Elena Chevez, Gloria Rey-Benito, Ondrej Mach
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:The Lancet Regional Health. Americas
Subjects:
Poliomyelitis
Fractional dose inactivated poliovirus vaccine
Routine immunization
Seroprevalence assay
Ecuador
Online Access:http://www.sciencedirect.com/science/article/pii/S2667193X22000527

Internet

http://www.sciencedirect.com/science/article/pii/S2667193X22000527

Similar Items